Anti-infective antibodies: A novel tool to prevent and treat nosocomial diseases

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 1, 2008, Pages 21-30

  Nagy, Eszter ^a   Giefing, Carmen ^a   von Gabain, Alexander ^a,b,c  

^a INTERCELL AG   (Austria)

^b MAX F PERUTZ LABORATORIES   (Austria)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anti infective monoclonal antibodies; Nosocomial infection

Indexed keywords

ALTASTAPH; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AUROGRAB; BACTERIAL VACCINE; CYCLOPHOSPHAMIDE; ENTEROCOCCAL MONOCLONAL ANTIBODY; ETI 211; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3; KB 001; KBPA 101; KBSA 301; KBSA 302; METICILLIN; MONOCLONAL ANTIBODY; MYCOGRAB; NEUTRALIZING ANTIBODY; PSEUDOMONAS VACCINE; RECOMBINANT ANTIBODY; STAPHYLOCOCCUS AUREUS MONOCLONAL ANTIBODY; STAPHYLOCOCCUS EPIDERMIDIS MONOCLONAL ANTIBODY; STAPHYLOCOCCUS VACCINE; TEFIBAZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; VERONATE;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; DRUG TREATMENT FAILURE; DRUG USE; FUNGAL STRAIN; HOSPITAL INFECTION; HOST PARASITE INTERACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INFECTION CONTROL; INFECTION RISK; MONOTHERAPY; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMONIA; SEPSIS; VACCINE PRODUCTION;

EID: 40649127250     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.1.21     Document Type: Article

References (54)